Trial NCT04254107

View at ClinicalTrials.gov 
Org. Study IDs: SGNTGT-001

Last trial update was posted on 2024-01-19

MeSH Interventions

Brentuximab Vedotin

MeSH Conditions

Carcinoma Lymphoma Lymphoma, Large B-Cell, Diffuse Lymphoma, T-Cell, Peripheral Squamous Cell Carcinoma of Head and Neck Stomach Neoplasms Triple Negative Breast Neoplasms

Other Conditions

Bladder Cancer Cervical Cancer Classical Hodgkin Lymphoma Cutaneous Melanoma Diffuse Large B-cell Lymphoma Gastric Carcinoma Gastroesophageal Junction Carcinoma Head and Neck Squamous Cell Carcinoma Non-small Cell Lung Cancer Ovarian Cancer Peripheral T-cell Lymphoma Triple Negative Breast Cancer

Stopping Reasons

Study closed due to portfolio prioritization

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID